Interview with Johan Ström Managing Director, Biogen Idec Sweden
Having experienced many years at big pharmaceutical companies, you moved into the biotech sector by joining Biogen Idec late 2010. What made you decide to switch? To me, it was…
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. In 2008, Biogen Idec’s total revenues grew 29 percent over 2007 to $4.1 billion. Biogen Idec is headquartered in Cambridge, Massachusetts, with international headquarters in Zug, Switzerland. They have additional offices in the US, Canada, Australia, Japan and throughout Europe. Biogen Idec has a direct commercial presence in 29 markets, a network of distribution partners in more than 70 additional markets and operations in several new markets, including Central/Eastern Europe, Brazil, China and India.
Contact Info
BiogenIdec Sweden AB
Kanalvägen 12, Plan 5
19461 Upplands Väsby
Sweden
Phone: +46 8 5941 1360
Fax: +46 8 5941 1369
www.biogenidec.se
Having experienced many years at big pharmaceutical companies, you moved into the biotech sector by joining Biogen Idec late 2010. What made you decide to switch? To me, it was…
Region Stockholm is responsible for all publicly funded healthcare in the Stockholm region. Its chairman, Irene Svenonius, explains her agenda to transform and modernize the region’s healthcare system to improve…
Stefan James, president of the Swedish Society of Cardiology and director of research at the Uppsala Clinical Research Centre, outlines the goldmine of healthcare data that is Sweden’s quality registries…
Sweden’s pharmaceutical exports shot up 27% in first quarter 2019, continuing an upward growth trend in an industry that is increasingly well-renowned internationally for its quality and high technology. …
The Karolinska University Hospital in Stockholm is one of the largest teaching hospitals in Europe and a globally renowned healthcare institution. Björn Zoëga was recently appointed as its director after…
Dr Göran A. Ando, former chairman of Novo Nordisk and a Swedish life sciences industry veteran, recently moved back to his home country after over 35 years abroad. He shares…
Sweden’s comprehensive and high-quality system of electronic health records is increasingly in demand from international researchers in the machine learning and AI fields and is also facilitating significant breakthroughs in…
Gothenburg-headquartered Cellink has gone from a start-up to one of the world’s leading 3D bioprinting firms in just four years; firmly positioning Sweden at the forefront of this potentially revolutionary…
Swecare Foundation is a platform where academia, public sector actors, and the private sector come together to promote the internationalization and export growth of Swedish healthcare and life sciences. Anna…
Dr. Olsson Birgersson, Medical Director of Roche Sweden argues the importance of developing clinical research within Sweden, why the Swedish healthcare system is no longer the forerunner in Europe that…
Anders Blanck of Lif Sweden discusses the Swedish healthcare system, why it’s contributing to the plunging profit margins in the pharma market, and the Swedish government’s heavy emphasis on cost-effectiveness.…
The general manager of Baxter in the Nordic region discusses the concept of home care, and how brand new technologies currently being tested in Sweden should mean that soon, dialysis…
After working at Ipsen for seven years, of which you have spent four as the head of the Nordics, what would you say have been the company’s main milestones in…
See our Cookie Privacy Policy Here